These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2765598)

  • 1. Clinical ratings and plasma HVA during cocaine abstinence.
    Martin SD; Yeragani VK; Lodhi R; Galloway MP
    Biol Psychiatry; 1989 Aug; 26(4):356-62. PubMed ID: 2765598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
    Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
    Bowers MB; Malison RT; Seibyl JP; Kosten TR
    Biol Psychiatry; 1998 Feb; 43(4):278-81. PubMed ID: 9513737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
    Satel SL; Price LH; Palumbo JM; McDougle CJ; Krystal JH; Gawin F; Charney DS; Heninger GR; Kleber HD
    Am J Psychiatry; 1991 Dec; 148(12):1712-6. PubMed ID: 1957935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic responsivity during cocaine abstinence: a pilot study.
    McDougle CJ; Price LH; Palumbo JM; Kosten TR; Heninger GR; Kleber HD
    Psychiatry Res; 1992 Jul; 43(1):77-85. PubMed ID: 1359594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of beta-endorphin with HVA and MHPG in the plasma of prepubertal boys: effects of familial drug abuse and antisocial personality disorder liability.
    Moss HB; Yao JK
    Psychiatry Res; 1996 Jun; 62(3):203-11. PubMed ID: 8804130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral benzodiazepine receptors are decreased during cocaine withdrawal in humans.
    Javaid JI; Notorangelo MP; Pandey SC; Reddy PL; Pandey GN; Davis JM
    Biol Psychiatry; 1994 Jul; 36(1):44-50. PubMed ID: 8080902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biomodal distribution of plasma HVA/MHPG in the psychoses.
    Ottong SE; Garver DL
    Psychiatry Res; 1997 Mar; 69(2-3):97-103. PubMed ID: 9109177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving.
    Roy A; Berman J; Gonzalez B; Roy M
    J Psychopharmacol; 2002 Sep; 16(3):227-9. PubMed ID: 12236629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
    Kirch DG; Jaskiw G; Linnoila M; Weinberger DR; Wyatt RJ
    Psychiatry Res; 1988 Sep; 25(3):233-42. PubMed ID: 2903509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CSF HVA with craving in long-term abstinent cocaine abusers.
    Knoblich G; Curtis D; Faustman WO; Zarcone V; Stewart S; Mefford I; King R
    Biol Psychiatry; 1992 Jul; 32(1):96-100. PubMed ID: 1391298
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.
    Thibaut F; Ribeyre JM; Dourmap N; Ménard JF; Dollfus S; Petit M
    Biol Psychiatry; 1998 Jan; 43(1):24-30. PubMed ID: 9442341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol antagonism of cue-elicited cocaine craving.
    Berger SP; Hall S; Mickalian JD; Reid MS; Crawford CA; Delucchi K; Carr K; Hall S
    Lancet; 1996 Feb; 347(9000):504-8. PubMed ID: 8596268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
    Chang WH; Chen TY; Lin SK; Lung FW; Lin WL; Hu WH; Yeh EK
    Biol Psychiatry; 1990 Mar; 27(5):510-8. PubMed ID: 2310806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily cocaine craving in a 3-week inpatient treatment program.
    Flowers Q; Elder IR; Voris J; Sebastian PS; Blevins O; Dubois J
    J Clin Psychol; 1993 Mar; 49(2):292-7. PubMed ID: 8387547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 3-methoxy-4-hydroxyphenylethyleneglycol and homovanillic acid concentrations in patients with subarachnoid hemorrhage.
    Minegishi A; Ishizaki T; Yoshida Y; Ahagon A; Shibata N; Kobayashi H
    Stroke; 1987; 18(1):223-8. PubMed ID: 3810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
    Ueda N; Yoshimura R; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2002 Sep; 35(5):175-81. PubMed ID: 12237788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.